abstract |
The present invention relates to an immuno-stimulatory combination for the prophylaxis and treatment of hepatitis C, characterized in that it comprises: a TLR3 agonist, a CD40 agonist and the NS3 protein of the hepatitis C virus. On the other hand, the The invention relates to pharmaceutical compositions comprising said immunostimulatory combination, their use and a kit composed of said pharmaceutical compositions. Finally, the present invention relates to a method of producing an immune response against the hepatitis C virus, and a vaccine against said virus. |